🎄Is your CRO on the naughty list?🎅 Phastar is officially on the nice list! With an award-winning team of specialists, a track record of delivering results right the first time, and a sprinkling of fun along the way, we’re here to make your clinical trial journey seamless and successful. Discover more here: https://lnkd.in/eziuTHf9 #ClinicalTrials #CRO #NiceList
Phastar’s Post
More Relevant Posts
-
A snippet from our most recent webinar with Habitual on best practices for executing #consumerhealth trials, where Meri Beckwith talks #patientengagement tactics that have resulted in 95% adherence across our studies. Watch the full webinar: https://lnkd.in/dKptDN7V #consumerhealthresearch #patientretention #clinicaltrials #cro
To view or add a comment, sign in
-
Today we celebrate all that has been accomplished thanks to clinical trials and the people behind them. Happy clinical trials day to all fellow trailblazers (or should we say trialblazers 😉) in clinical research! #ClinicalTrialsDay #CTD2024 #medicaldevices #expert #CRO #humanhealth #archerresearch
To view or add a comment, sign in
-
Two important meetings on life science and clinical trials in one day: Partnership conference with Region Stockholm in the morning and 10 year anniversary of SWElife in the afternoon. Many important discussions and inspiring presentations! One message we take with us is that if there is a will, there is a way! #lifescience #partnership #clinicaltrials #cro #ascro
To view or add a comment, sign in
-
Southern Star Research guides you and your product through the complexities of running a clinical trial. Our people are leaders in their field and can help you accelerate your study and achieve optimal results. #CRO #ClinicalTrials #MedicalTrials #ClinicalResearch
To view or add a comment, sign in
-
The success of a clinical trial depends on a skilled Global Study Manager, meticulously coordinating diverse stakeholders and navigating unforeseen challenges. Meet Estelle de Bary, our expert behind seamless clinical trial studies at #Aixial Group. Watch her video for more insights about her expertise! #AixialGroup #CRO #GlobalStudyManager #ClinicalOperations
To view or add a comment, sign in
-
Timely communication within clinical trials is essential for success. Read the case study: https://lnkd.in/eh-tCixZ #clinicaltrials #clinicalresearch #CRO
To view or add a comment, sign in
-
During early study planning, determining how to run your #clinicalresearch—fully internally, or with a CRO—is a crucial decision. In our latest blog, we highlight considerations for both approaches as they relate to sponsors’ goals and internal capabilities. Read the blog: https://lnkd.in/esWEkBzX #cro #clinicaltrials #drugdevelopment
To view or add a comment, sign in
-
When evaluating proposals from Contract Research Organizations (CROs) for phase 1 trials, it's crucial to look for key elements that ensure a successful partnership. By focusing on these must-haves, you can make informed decisions that enhance the efficiency and effectiveness of your clinical research. To learn more about partnering with the right phase 1 CRO, check out this article: https://hubs.li/Q02ZvcL70 #ClinicalResearch #CRO #ClinicalTrials #Phase1
To view or add a comment, sign in
-
Unlocking Global Potential: ACROSS Global™ - Your Trusted Partner in Over 90 Countries. Introducing our extensive CRO services, designed to drive success across borders. Learn how we can elevate your clinical trials today! #AcrossGlobal #AcrossGlobalAlliance #ClinicalResearch #CRO #GlobalHealthcare #GlobalPresence #CROServices
To view or add a comment, sign in
-
Acadia Pharmaceuticals Inc. has sold its FDA Priority Review Voucher (PRV) for $150 million following the approval of Daybue, a treatment for Rett syndrome, earning them one of the highest publicly-announced PRV prices in years. The PRV, granted for rare pediatric disease approvals, allows faster FDA review times and can be sold or used by the company. Acadia will allocate part of the sale proceeds to Neuren Pharmaceuticals Limited Pharmaceuticals, which licensed Daybue to Acadia in 2018, with Neuren expected to receive approximately $50 million. Acadia plans to use the remaining funds to bolster its commercial operations, central nervous system and rare disease R&D, and future business development. #biopharma #biotech #pharmaceuticals #lifesciences #lifescience #Biopharma #PriorityReviewVoucher #RareDiseases #FDAApproval #RettSyndrome #Biotech #PRV #fundinggrowth #raredisease #rettsyndrome #commercialoperations #creativefinancing #fundingcommercial #150m #CNS #researchanddevelopment #businessdevelopment
To view or add a comment, sign in
31,470 followers